NCT01969773View on ClinicalTrials.gov

Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Interstitial Cystitis
Interventions
DRUG

Botulinum toxin A

Patients will be randomly assigned to receive intravesical injection of 100U of BoNT-A (BOTOX, Allergan, Irvine, CA, USA)

DRUG

Normal saline instillation

Patients will be randomly assigned to receive intravesical injection of injection with normal saline.

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors
lead

Buddhist Tzu Chi General Hospital

OTHER

NCT01969773 - Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment | Biotech Hunter | Biotech Hunter